Source comparison
Melanotan-1 vs Melanotan-2: The Real Distinction That Matters
The confusion between MT-1 and MT-2 is understandable. Both are synthetic melanocortins developed from the same precursor research. But their pharmacology diverges significantly. Melanotan-2 (MT-2) is a cyclic heptapeptide analog with a disulfide bridge, struc
This comparison does not assign a generated winner or score.
- The confusion between MT-1 and MT-2 is understandable. Both are synthetic melanocortins developed from the same precursor research. But their pharmacology diverges significantly. Melanotan-2 (MT-2) is a cyclic heptapeptide analog with a disulfide bridge, structurally modified to increase potency and reduce peptide length. That structural change produces broader melanocortin receptor binding: MT-2 activates MC1R, MC3R, MC4R, and MC5R with nearly equal affinity, which is why users report appetite suppression, libido changes, and nausea alongside pigmentation.
- Melanotan-1 is a linear 13-amino-acid sequence with high MC1R selectivity. It does not produce the central nervous system effects associated with MT-2 because it does not cross the blood-brain barrier efficiently and does not activate MC4R (the receptor implicated in appetite and sexual arousal pathways). Clinical trials of afamelanotide for EPP. A condition requiring months of continuous dosing. Report minimal adverse events beyond injection-site reactions and mild nausea in fewer than 5% of participants. MT-2 anecdotal reports consistently describe nausea rates above 30% and spontaneous erections in male users.
- Dosing further differentiates them. MT-1 therapeutic protocols use 16 mg subcutaneous implants that release 1 mg per day over 60 days (Scenesse formulation), or daily injections of 0.5–1.0 mg for research applications. MT-2 dosing is typically 0.25–1.0 mg per injection due to higher potency per milligram. The peptides are not interchangeable. Substituting one for the other in a research protocol would alter both the melanogenic effect and the side effect profile.